CoChat

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND: People who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated. METHODS: Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incidence were evaluated. Factors associated with time to HCV infection were assessed using Cox proportional hazards regression. RESULTS: Among 2,589, 82% (n = 2,121) were HCV antibody-positive at enrollment. Among 364 HCV antibody-negative participants with recent (last 30 days) injecting at enrollment, 126 HCV seroconversions were observed [Overall HCV incidence density: 8.6 cases/100 person-years (py); 95% confidence interval (95% CI): 7.2, 10.1; HCV incidence density among those with injecting during follow-up: 11.5 cases/100 py; 95% CI 9.7, 13.6]. The overall HCV incidence density declined significantly from 25.0/100 py (95% CI: 20.2, 30.3) in 1996-99, as compared to 6.0/100 py (95% CI: 4.1, 8.5) in 2000-2005, and 3.1/100 py (95% CI: 2.0, 4.8) in 2006-2012. Among those with injecting during follow-up, the overall HCV incidence density declined significantly from 27.9/100 py (95% CI: 22.6, 33.6) in 1996-99, as compared to 7.5/100 py (95% CI: 5.1, 10.6) in 2000-2005, and 4.9/100 py (95% CI: 3.1, 7.4) in 2006-2012. Unstable housing, HIV infection, and injecting of cocaine, heroin and methamphetamine were independently associated with HCV seroconversion. CONCLUSIONS: HCV incidence has dramatically declined among PWID in this setting. However, improved public health strategies to prevent and treat HCV are urgently required to reduce HCV-associated morbidity and mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0097726

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Participant disposition.
Figure 1 Participant disposition.CC BY · PubMed Central
Figure 2 Trends in syringe borrowing and drug use at enrolment among HCV antibody negative PWID enrolled in the VIDUS cohort in Vancouver, Canada by year of enrollment.
Figure 2 Trends in syringe borrowing and drug use at enrolment among HCV antibody negative PWID enrolled in the VIDUS cohort in Vancouver, Canada by year of enrollment.CC BY · PubMed Central
Figure 3 Annual incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort between 1996 and 2012. A) overall population (injecting at enrolment); B) those with person-years of injecting during follow-up. The circles indicate the HCV incidence density (per 100 person years) and the lines indicate the 95% confidence intervals (95% CI).
Figure 3 Annual incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort between 1996 and 2012. A) overall population (injecting at enrolment); B) those with person-years of injecting during follow-up. The circles indicate the HCV incidence density (per 100 person years) and the lines indicate the 95% confidence intervals (95% CI).CC BY · PubMed Central
Figure 4 Incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort by year of study enrollment in: A) the overall population; B) those with person-years of injecting during follow-up; and calendar year of observation in: C) the overall population; and D) those with person-years of injecting during follow-up. The circles indicate the HCV incidence density (per 100 person years) and the lines indicate the 95% confidence intervals (95% CI).
Figure 4 Incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort by year of study enrollment in: A) the overall population; B) those with person-years of injecting during follow-up; and calendar year of observation in: C) the overall population; and D) those with person-years of injecting during follow-up. The circles indicate the HCV incidence density (per 100 person years) and the lines indicate the 95% confidence intervals (95% CI).CC BY · PubMed Central
Figure 5 Incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort by calendar year of enrolment and calendar year of observation. Each shaded area is a proportion relative to the largest incidence rate with 25.0 being 1 (full shading). The numeric values of the rates are used as the labels [95% CI]. Cells with N/A are blank.
Figure 5 Incidence density of HCV infection (per 100 person-years) among PWID in the VIDUS cohort by calendar year of enrolment and calendar year of observation. Each shaded area is a proportion relative to the largest incidence rate with 25.0 being 1 (full shading). The numeric values of the rates are used as the labels [95% CI]. Cells with N/A are blank.CC BY · PubMed Central
Figure 6 Kaplan-Meier graphs of time to HCV seroconversion by calendar year of enrolment between 1996 and 2012 among PWID in the VIDUS cohort (truncated at 5 years of follow-up).
Figure 6 Kaplan-Meier graphs of time to HCV seroconversion by calendar year of enrolment between 1996 and 2012 among PWID in the VIDUS cohort (truncated at 5 years of follow-up).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 48

Metadata

Authors
Grebely, J., Lima, V. D., Marshall, B. D. L., Milloy, M.-J., DeBeck, K., Montaner, J., Simo, A., Krajden, M., Dore, G. J., Kerr, T., & Wood, E.
Affiliations
  • UNSW Sydney (AU)
  • University of British Columbia (CA)
  • Brown University (US)
  • Simon Fraser University (CA)
  • BC Centre for Disease Control (CA)
Corresponding author
Grebely, Jason
Venue
PLoS ONE
Published
2014-06-04
Volume
9
Issue
6
Pages
e97726
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2038073312
Cited by
48
References
37
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 2
FWCI
4.65
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Summit (Simon Fraser University) (submittedVersion, cc-by)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by)
Funders
  • Bristol-Myers Squibb
  • World Health Organization
  • Gilead Sciences
  • UNICEF
  • U.S. President’s Emergency Plan for AIDS Relief
  • ViiV Healthcare
  • Providence Health Care
  • Australian Government
  • Michael Smith Health Research BC
  • Canada Research Chairs (Tier1)
  • Simon Fraser University
  • Ministry of Health, British Columbia (1DP1DA026182, R01DA011591)
  • University of British Columbia
  • International AIDS Society
  • National Institutes of Health
  • Canadian Institutes of Health Research (R01DA011591, RAA- 79918, HES- 115697, 129971_1, 125948_1, HHP- 67262)
  • National Health and Medical Research Council
  • National Institute on Drug Abuse (DP1DA026182, R03DA033851, R01DA011591)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
hepatitis C virus, people who inject drugs, HCV seroconversion, intravenous drug use, cocaine use, heroin use, methamphetamine use, HIV coinfection, unstable housing, risk factors, Vancouver, harm reduction, needle exchange programs, HCV screening, HCV seroprevalence
MeSH terms
Adult, Canada, Female, Hepatitis C, Humans, Male, Surveys and Questionnaires, Risk Factors, Substance Abuse, Intravenous, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012. https://app.cochat.ai/papers/10.1371/journal.pone.0097726
The paper
Grebely, J., Lima, V. D., Marshall, B. D. L., Milloy, M.-J., DeBeck, K., Montaner, J., Simo, A., Krajden, M., Dore, G. J., Kerr, T., & Wood, E. (2014). Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012. PLoS ONE. https://doi.org/10.1371/journal.pone.0097726

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.